# PROSTATE LUNG COLORECTAL OVARIAN (PLCO) ETIOLOGIC AND EARLY MARKER STUDIES (EEMS)

> **NIH NIH N02** · INFORMATION MANAGEMENT SERVICES, INC. · 2024 · $1,193,091

## Abstract

The Etiologic and Early Marker Studies (EEMS) is a component of the Prostate Lung Colorectal and Ovarian (PLCO) Trial. By collecting biologic materials and risk factor information from participants, PLCO EEMS
provides a rich resource for research on cancer etiology and early detection biomarkers. The PLCO Biorepository stores approximately 2.9 million biologic specimens collected from PLCO participants. These specimens and their associated data are available to all qualified researchers through an application and peer-review process. EEMS also covers tissue specimens from the LSS component of the National Lung Screening Trial (NLST).

## Key facts

- **NIH application ID:** 11115521
- **Project number:** 75N91021D00017-P00002-759102200002-1
- **Recipient organization:** INFORMATION MANAGEMENT SERVICES, INC.
- **Principal Investigator:** THOMAS RILEY
- **Activity code:** N02 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $1,193,091
- **Award type:** —
- **Project period:** 2022-07-20 → 2025-07-19

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11115521

## Citation

> US National Institutes of Health, RePORTER application 11115521, PROSTATE LUNG COLORECTAL OVARIAN (PLCO) ETIOLOGIC AND EARLY MARKER STUDIES (EEMS) (75N91021D00017-P00002-759102200002-1). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/11115521. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*